{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:35:16Z","timestamp":1784561716795,"version":"3.55.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.tox.2021.152858","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T11:54:02Z","timestamp":1626263642000},"page":"152858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The efficacy and toxicity of antineoplastic antimetabolites: Role of gut microbiota"],"prefix":"10.1016","volume":"460","author":[{"given":"Xinyi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1743-8610","authenticated-orcid":false,"given":"Dongsheng","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2021.152858_bib0005","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00384-017-2819-3","article-title":"Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0","volume":"32","author":"Aarnoutse","year":"2017","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.tox.2021.152858_bib0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2021.152858_bib0015","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4014\/jmb.1605.05024","article-title":"Combination therapy of Lactobacillus plantarum supernatant and 5-Fluouracil increases chemosensitivity in colorectal cancer cells","volume":"26","author":"An","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.tox.2021.152858_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/jama.1962.03050300015003","article-title":"Five years clinical experience with 5-fluorouracil","volume":"181","author":"Ansfield","year":"1962","journal-title":"Jama"},{"key":"10.1016\/j.tox.2021.152858_bib0025","doi-asserted-by":"crossref","first-page":"G22","DOI":"10.1152\/ajpgi.00229.2017","article-title":"Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM\/DSS mouse model of colon cancer","volume":"314","author":"Bader","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tox.2021.152858_bib0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/01635580903407197","article-title":"Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis","volume":"62","author":"Baldwin","year":"2010","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.tox.2021.152858_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.0767-3981.2003.00206.x","article-title":"Gemcitabine-induced severe pulmonary toxicity","volume":"18","author":"Barl\u00e9si","year":"2004","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2021.152858_bib0040","first-page":"359","article-title":"NCCN guidelines insights: colon cancer, version 2.2018","volume":"16","author":"Benson","year":"2018","journal-title":"J. Compr. Canc. Netw."},{"key":"10.1016\/j.tox.2021.152858_bib0045","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/cpt.1124","article-title":"Therapeutic drug monitoring in oncology: international association of therapeutic drug monitoring and clinical toxicology recommendations for 5-fluorouracil therapy","volume":"105","author":"Beumer","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2021.152858_bib0050","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tox.2021.152858_bib0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-micro-102215-095513","article-title":"Gut microbiota, inflammation, and colorectal cancer","volume":"70","author":"Brennan","year":"2016","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.tox.2021.152858_bib0060","series-title":"Cancer Mortality Database","author":"Cancer I.A.f.R.o","year":"2019"},{"key":"10.1016\/j.tox.2021.152858_bib0065","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/13543776.2015.1056736","article-title":"5-Fluorouracil derivatives: a patent review (2012-2014)","volume":"25","author":"Carrillo","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.tox.2021.152858_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11060-014-1362-0","article-title":"Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme","volume":"117","author":"Champ","year":"2014","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.tox.2021.152858_bib0075","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3389\/fmicb.2018.00983","article-title":"Lactobacillus casei variety rhamnosus probiotic preventively attenuates 5-fluorouracil\/oxaliplatin-induced intestinal injury in a syngeneic colorectal cancer model","volume":"9","author":"Chang","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tox.2021.152858_bib0080","first-page":"21","article-title":"Fecal microbiota transplantation prevents intestinal injury, upregulation of toll-like receptors, and 5-fluorouracil\/oxaliplatin-induced toxicity in colorectal cancer","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2021.152858_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109829","article-title":"Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota","volume":"124","author":"Chen","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tox.2021.152858_bib0090","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/14737159.2018.1544495","article-title":"The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine","volume":"18","author":"Choy","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.tox.2021.152858_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102988","article-title":"The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice","volume":"153","author":"Claessens","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tox.2021.152858_bib0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ecco-jcc\/jjaa143","article-title":"Gut microbiota-driven drug metabolism in inflammatory bowel disease","volume":"15","author":"Crouwel","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.tox.2021.152858_bib0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-198916040-00002","article-title":"Clinical pharmacology of 5-fluorouracil","volume":"16","author":"Diasio","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.tox.2021.152858_bib0110","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/cncr.27862","article-title":"Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer","volume":"119","author":"Duldulao","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.tox.2021.152858_bib0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijmm.2007.05.011","article-title":"Escherichia coli isolated from a Crohn\u2019s disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells","volume":"298","author":"Eaves-Pyles","year":"2008","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.tox.2021.152858_bib0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0003-9861(57)90028-0","article-title":"Effect of 5-fluorouracil on the incorporation of precursors into nucleic acid pyrimidines","volume":"71","author":"Eidinoff","year":"1957","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tox.2021.152858_bib0125","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1517\/14656566.8.18.3251","article-title":"Gemcitabine in bladder cancer","volume":"8","author":"El Karak","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.tox.2021.152858_bib0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11745-012-3680-3","article-title":"Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-Fluorouracil administration","volume":"47","author":"Ferreira","year":"2012","journal-title":"Lipids"},{"key":"10.1016\/j.tox.2021.152858_bib0135","first-page":"1513","article-title":"Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model","volume":"23","author":"Fijlstra","year":"2015","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.tox.2021.152858_bib0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ijantimicag.2016.07.011","article-title":"Susceptibility of lactic acid bacteria, bifidobacteria and other bacteria of intestinal origin to chemotherapeutic agents","volume":"48","author":"Florez","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.tox.2021.152858_bib0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/19490976.2017.1387343","article-title":"Colonic thioguanine pro-drug: investigation of microbiome and novel host metabolism","volume":"9","author":"Florin","year":"2018","journal-title":"Gut Microbes"},{"issue":"431\u2013441","key":"10.1016\/j.tox.2021.152858_bib0150","first-page":"e438","article-title":"Bacterial metabolism affects the C. elegans response to cancer chemotherapeutics","volume":"169","author":"Garc\u00eda-Gonz\u00e1lez","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tox.2021.152858_bib0155","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.tox.2021.152858_bib0160","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.634874","article-title":"Butyrate suppresses glucose metabolism of colorectal cancer cells via GPR109a-AKT signaling pathway and enhances chemotherapy","volume":"8","author":"Geng","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tox.2021.152858_bib0165","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41397-018-0047-z","article-title":"Genetic markers in methotrexate treatments","volume":"18","author":"Giletti","year":"2018","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.tox.2021.152858_bib0170","first-page":"118","article-title":"NCCN guidelines insights: breast cancer, version 3.2018","volume":"17","author":"Goetz","year":"2019","journal-title":"J. Compr. Canc. Netw."},{"key":"10.1016\/j.tox.2021.152858_bib0175","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1039\/C5FO00120J","article-title":"The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells","volume":"6","author":"Gonz\u00e1lez-Sarr\u00edas","year":"2015","journal-title":"Food Funct."},{"key":"10.1016\/j.tox.2021.152858_bib0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bcpt.12793","article-title":"Apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of 5-fluorouracil-induced intestinal mucositis in mice","volume":"121","author":"Hamouda","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.tox.2021.152858_bib0185","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00394-017-1542-8","article-title":"Decaffeinated green and black tea polyphenols decrease weight gain and alter microbiome populations and function in diet-induced obese mice","volume":"57","author":"Henning","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.tox.2021.152858_bib0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri2710","article-title":"Immune adaptations that maintain homeostasis with the intestinal microbiota","volume":"10","author":"Hooper","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tox.2021.152858_bib0195","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.tox.2021.152858_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114900","article-title":"Leucovorin ameliorated methotrexate induced intestinal toxicity via modulation of the gut microbiota","volume":"391","author":"Huang","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2021.152858_bib0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2021.152858_bib0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/138945010790031072","article-title":"Predictive markers for haematological toxicity of pemetrexed","volume":"11","author":"Kao","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.tox.2021.152858_bib0215","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/1440-1681.12792","article-title":"Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses","volume":"44","author":"Kato","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.tox.2021.152858_bib0220","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tox.2021.152858_bib0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2016.08.001","article-title":"The role of pharmacogenetics in capecitabine efficacy and toxicity","volume":"50","author":"Lam","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tox.2021.152858_bib0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.chom.2019.06.011","article-title":"Precision medicine goes microscopic: engineering the microbiome to improve drug outcomes","volume":"26","author":"Lam","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tox.2021.152858_bib0235","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-mercaptopurine","volume":"43","author":"Lennard","year":"1992","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2021.152858_bib0240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0738-081X(89)90014-X","article-title":"Methotrexate","volume":"7","author":"Lester","year":"1989","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.tox.2021.152858_bib0245","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1021\/acs.jproteome.0c00230","article-title":"A two-way interaction between methotrexate and the gut microbiota of male Sprague-Dawley rats","volume":"19","author":"Letertre","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.tox.2021.152858_bib0250","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fcimb.2017.00455","article-title":"Alteration of gut microbiota and inflammatory cytokine\/chemokine profiles in 5-fluorouracil induced intestinal mucositis","volume":"7","author":"Li","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tox.2021.152858_bib0255","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320904293","article-title":"Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX","volume":"11","author":"Li","year":"2020","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"6","key":"10.1016\/j.tox.2021.152858_bib0260","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1002\/jcp.30197","article-title":"Tumor-derived exosomes in the PD-1\/PD-L1 axis: significant regulators as well as promising clinical targets","volume":"236","author":"Liang","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tox.2021.152858_bib0265","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tox.2021.152858_bib0270","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The impact of dietary Fiber on gut microbiota in host health and disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tox.2021.152858_bib0275","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.tpj.6500320","article-title":"Genetic factors influencing pyrimidine-antagonist chemotherapy","volume":"5","author":"Maring","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.tox.2021.152858_bib0280","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2021.152858_bib0285","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s10620-006-9464-y","article-title":"Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats","volume":"52","author":"Mauger","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tox.2021.152858_bib0290","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3389\/fmicb.2018.00964","article-title":"Phagocytosis and epithelial cell invasion by Crohn\u2019s disease-associated adherent-invasive escherichia coli are inhibited by the anti-inflammatory drug 6-mercaptopurine","volume":"9","author":"Migliore","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tox.2021.152858_bib0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13167-015-0035-1","article-title":"The role of beneficial bacteria wall elasticity in regulating innate immune response","volume":"6","author":"Mokrozub","year":"2015","journal-title":"EPMA J."},{"key":"10.1016\/j.tox.2021.152858_bib0300","doi-asserted-by":"crossref","first-page":"9277","DOI":"10.1007\/s00253-019-10165-x","article-title":"Antibiotic effects on gut microbiota, metabolism, and beyond","volume":"103","author":"Mu","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.tox.2021.152858_bib0305","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ibd.21462","article-title":"Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis","volume":"17","author":"Nagalingam","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"issue":"362\u2013377","key":"10.1016\/j.tox.2021.152858_bib0310","first-page":"e311","article-title":"Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation","volume":"29","author":"Nayak","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tox.2021.152858_bib0315","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: causation or correlation?","volume":"14","author":"Ni","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2021.152858_bib0320","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/gutjnl-2015-310874","article-title":"Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism","volume":"66","author":"Oancea","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.tox.2021.152858_bib0325","series-title":"World Health Statistics","author":"Organization","year":"2020"},{"key":"10.1016\/j.tox.2021.152858_bib0330","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.2174\/092986711797287584","article-title":"Development of 5-Fluorouracil derivatives as anticancer agents","volume":"18","author":"Pan","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tox.2021.152858_bib0335","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00280-018-3549-0","article-title":"Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice","volume":"81","author":"Panebianco","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tox.2021.152858_bib0340","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40168-018-0483-7","article-title":"Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies","volume":"6","author":"Panebianco","year":"2018","journal-title":"Microbiome"},{"issue":"9","key":"10.1016\/j.tox.2021.152858_bib0345","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2174\/1389200220666190806140844","article-title":"Methotrexate overdose in clinical practice","volume":"20","author":"Pannu","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tox.2021.152858_bib0350","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/cr900028p","article-title":"Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer","volume":"109","author":"Parker","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tox.2021.152858_bib0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1152\/physrev.1952.32.2.197","article-title":"Folic acid antagonists","volume":"32","author":"Petering","year":"1952","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tox.2021.152858_bib0360","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1503\/cmaj.181054","article-title":"Low-dose methotrexate toxicity","volume":"191","author":"Pivovarov","year":"2019","journal-title":"CMAJ"},{"key":"10.1016\/j.tox.2021.152858_bib0365","doi-asserted-by":"crossref","first-page":"15632","DOI":"10.3748\/wjg.v20.i42.15632","article-title":"Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics","volume":"20","author":"Plaza-Diaz","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tox.2021.152858_bib0370","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2021.152858_bib0375","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4161\/cbt.11.7.14896","article-title":"Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats","volume":"11","author":"Prisciandaro","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tox.2021.152858_bib0380","first-page":"1312","article-title":"NCCN guidelines insights: colorectal cancer screening, version 2.2020","volume":"18","author":"Provenzale","year":"2020","journal-title":"J. Compr. Canc. Netw."},{"key":"10.1016\/j.tox.2021.152858_bib0385","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11912-003-0098-3","article-title":"Novel antifolate drugs","volume":"5","author":"Purcell","year":"2003","journal-title":"Curr. Oncol. Rep."},{"issue":"6","key":"10.1016\/j.tox.2021.152858_bib0390","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/biof.1565","article-title":"Glucorticoid-induced obesity individuals have distinct signatures of the gut microbiome","volume":"45","author":"Qiu","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/j.tox.2021.152858_bib0395","first-page":"1108","article-title":"Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology","volume":"16","author":"Radich","year":"2018","journal-title":"J. Compr. Canc. Netw."},{"key":"10.1016\/j.tox.2021.152858_bib0400","doi-asserted-by":"crossref","DOI":"10.1093\/femsec\/fiw098","article-title":"Degree of colitis correlates with microbial composition and cytokine responses in colon and caecum of G\u03b1i2-deficient mice","volume":"92","author":"Rangel","year":"2016","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.tox.2021.152858_bib0405","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gene.2013.11.081","article-title":"Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity","volume":"537","author":"Remely","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.tox.2021.152858_bib0410","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/leu.2017.283","article-title":"High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG","volume":"32","author":"Sakura","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.tox.2021.152858_bib0415","first-page":"61","article-title":"Probiotics, gut microbiota, and their influence on host health and disease","author":"S\u00e1nchez","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.tox.2021.152858_bib0420","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2017.05.010","article-title":"Azacitidine in adult patients with acute myeloid leukemia","volume":"116","author":"Schuh","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tox.2021.152858_bib0425","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0021-9258(19)41709-2","article-title":"Transport and metabolism of folates by bacteria","volume":"250","author":"Shane","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2021.152858_bib0430","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0166-3542(89)90012-0","article-title":"The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomegalovirus in vitro","volume":"11","author":"Shanley","year":"1989","journal-title":"Antiviral Res."},{"key":"10.1016\/j.tox.2021.152858_bib0435","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nut.2018.02.005","article-title":"Anti-inflammatory effect of multistrain probiotic formulation (L. rhamnosus, B. lactis, and B. longum)","volume":"53","author":"Sichetti","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.tox.2021.152858_bib0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mito.2014.05.010","article-title":"Components of cancer metabolism and therapeutic interventions","volume":"17","author":"Singleterry","year":"2014","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tox.2021.152858_bib0445","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1038\/s41598-020-69112-w","article-title":"17\u03b2-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice","volume":"10","author":"Song","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2021.152858_bib0450","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2019.02.020","article-title":"Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota","volume":"80","author":"Sougiannis","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tox.2021.152858_bib0455","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004270.pub2","article-title":"Purine antagonists for chronic lymphocytic leukaemia","author":"Steurer","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tox.2021.152858_bib0460","first-page":"259","article-title":"Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment","volume":"5","author":"Stringer","year":"2007","journal-title":"J. Support. Oncol."},{"key":"10.1016\/j.tox.2021.152858_bib0465","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3181\/0810-RM-301","article-title":"Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis","volume":"234","author":"Stringer","year":"2009","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tox.2021.152858_bib0470","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics","volume":"25","author":"Suez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2021.152858_bib0475","first-page":"1","article-title":"Dietary restriction increases protective gut bacteria to rescue lethal methotrexate-induced intestinal toxicity","author":"Tang","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.tox.2021.152858_bib0480","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/10408398.2018.1555789","article-title":"Targeting gut microbiota with dietary components on cancer: effects and potential mechanisms of action","volume":"60","author":"Tao","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.tox.2021.152858_bib0485","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apt.12878","article-title":"Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications","volume":"40","author":"Touchefeu","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2021.152858_bib0490","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tox.2021.152858_bib0495","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0006-2952(72)90125-6","article-title":"Studies of the metabolism of methotrexate by intestinal flora. I. Identification and study of biological properties of the metabolite 4-amino-4-deoxy-N 10 -methylpteroic acid","volume":"21","author":"Valerino","year":"1972","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2021.152858_bib0500","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejca.2003.12.004","article-title":"Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil","volume":"40","author":"van Kuilenburg","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tox.2021.152858_bib0505","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.hoc.2012.02.002","article-title":"The antifolates","volume":"26","author":"Visentin","year":"2012","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.tox.2021.152858_bib0510","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","article-title":"Capecitabine: a review","volume":"27","author":"Walko","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tox.2021.152858_bib0515","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1142\/S0192415X1950071X","article-title":"Chemo-preventive potential of falcarindiol-enriched fraction from oplopanax elatus on colorectal cancer Interfered by human gut microbiota","volume":"47","author":"Wang","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.tox.2021.152858_bib0520","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0065-2571(83)90007-9","article-title":"Some regulatory and integrative aspects of purine nucleotide biosynthesis and its control: an overview","volume":"21","author":"Watts","year":"1983","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.tox.2021.152858_bib0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcancer.2020.06.007","article-title":"Diet and cancer risk reduction: the role of diet-microbiota interactions and microbial metabolites","volume":"70","author":"Weir","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tox.2021.152858_bib0530","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.tox.2021.152858_bib0535","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0022-3565(24)39150-5","article-title":"Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid","volume":"294","author":"Widemann","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2021.152858_bib0540","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","article-title":"Gut microbiome interactions with drug metabolism, efficacy, and toxicity","volume":"179","author":"Wilson","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.tox.2021.152858_bib0545","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrclinonc.2014.51","article-title":"Standing the test of time: targeting thymidylate biosynthesis in cancer therapy","volume":"11","author":"Wilson","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tox.2021.152858_bib0550","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.tranon.2014.04.014","article-title":"Fasting reduces the incidence of delayed-type vomiting associated with doxorubicin treatment in dogs with lymphoma","volume":"7","author":"Withers","year":"2014","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tox.2021.152858_bib0555","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-015-0158-9","article-title":"Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia","volume":"8","author":"Wojtuszkiewicz","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tox.2021.152858_bib0560","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","article-title":"Gut microbiota in colorectal cancer: mechanisms of action and clinical applications","volume":"16","author":"Wong","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2021.152858_bib0565","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.lfs.2019.04.009","article-title":"In vivo pharmacodynamic and pharmacokinetic effects of metformin mediated by the gut microbiota in rats","volume":"226","author":"Wu","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2021.152858_bib0570","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/jgh.14890","article-title":"Modulations of probiotics on gut microbiota in a 5-fluorouracil-induced mouse model of mucositis","volume":"35","author":"Yeung","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2021.152858_bib0575","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13045-020-00998-9","article-title":"Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy","volume":"13","author":"Yilmaz","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tox.2021.152858_bib0580","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biopha.2018.08.165","article-title":"The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer","volume":"108","author":"Yuan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tox.2021.152858_bib0585","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-019-1065-y","article-title":"Structural variation in the gut microbiome associates with host health","volume":"568","author":"Zeevi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tox.2021.152858_bib0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165884","article-title":"5-Fluorouracil induced dysregulation of the microbiome-gut-brain axis manifesting as depressive like behaviors in rats","volume":"1866","author":"Zhang","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.tox.2021.152858_bib0595","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2018.06.029","article-title":"Induction and amelioration of methotrexate-induced gastrointestinal toxicity are related to immune response and gut microbiota","volume":"33","author":"Zhou","year":"2018","journal-title":"EBioMedicine"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21001815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21001815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:46:12Z","timestamp":1759535172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X21001815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":119,"alternative-id":["S0300483X21001815"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2021.152858","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and toxicity of antineoplastic antimetabolites: Role of gut microbiota","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2021.152858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"152858"}}